acquisition of a hexavalent combined vaccine against acellular perineal diphtheriatetanus, injectable poliomyelitis, haemophillus influenzae type b and hepatitis b (dtpavpihibvhb), for the capv vaccination program, in the terms that appear in the specifications of particular technical requirements. at Spain
Classified in :
#Injection
#Vaccines
Partner Opportunity
Key Values
| Worth | : | € 820440000.0 |
| EMD | : | Refer Document |
| Doc Fees | : | Refer Document |
Key Date
| Due on | : | 30-Jul-2024 |
| Days to go | : | -462 Days |
| Opening on | : | Refer Document |
| Published on | : | 13-Jul-2024 |
Key Location
| Location | : | Spain |
| Address | : |
|
